The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible HIV vaccines and other biomedical tools to prevent HIV infection. Founded in 1996, IAVI works with government agencies, civil society, clinical and community partners around the world to research, design, and develop AIDS vaccine candidates. Since its founding, IAVI has amassed scientific and clinical capital to address other emerging infectious diseases to illuminate the path toward an AIDS vaccine.
IAVI believes that a sustainable path to ending the epidemic will come from strengthening scientific systems in parts of the world where HIV continues to challenge population health. IAVI’s comprehensive approach balances the expansion and strengthening of existing HIV prevention and treatment programs with targeted investments in the design and development of new prevention tools. IAVI also conducts policy analyses and serves as an advocate for peers in the AIDS prevention field.
Dedicated to ensuring that a future AIDS vaccine will be available and accessible to all who need it, IAVI relies on the generous donations of governments, private individuals, corporations, and foundations to carry out its mission.